Table of contents

Original research

• Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance (7 January, 2021)

  Yan-xia Yu, Jian Lu, Hao-di Lu, Lan Li, Jing-jing Li, Lu Shi, Lu-fen duan, Zhi-wei Zhuang, Su-dong Xue, Yi Shen, Lian Tang
• Outcomes of Clostridioides difficile infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study

  (12 February, 2021)

  Bojana Milenković, Vesna Šuljagić, Aneta Perić, Viktorija Dragojević-Simić, Olivera Tarabar, Milomir Milanović, Vesna Putić, Diana Tomić, Branislava Miljković, Sandra Vezmar Kovačević
• The European COVID-19 drugs calculation tool: an aid for the estimation of the drugs needed during the SARS-CoV 2 pandemic (22 February, 2021)

  Daniele Leonardi Vinci, Adriano Meccio, Alessio Provenzani, Maria Ernestina Faggiano, Nenad Miljković, Despina Makridaki, Petr Horák, Piera Polidori
• Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital (11 March, 2021)

  Maxime Perez, Morgane Masse, Anne Deldicque, Jean Baptiste Beuscart, Pascal De Groote, Jacques Desbordes, Stéphanie Fry, Elodie Musy, Pascal Odou, Francois Puisieux, Marc Lambert, Arnaud Scherpereel, Bertrand Décaudin
• Hospital pharmacy response to COVID-19 at two UK teaching hospitals: a departmental review of actions implemented to inform future strategy (14 April, 2021)

  Jeff Aston, Inderjit Singh, Caroline Cheng, Aisling Considine
• Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients (28 July, 2021)

  Rubén Iglesias Gómez, Raúl Méndez, Tomás Palanques-Pastor, Octavio Ballesta-López, Conxa Borrás Almenar, Juan Eduardo Megías Vericat, Eduardo López-Briz, Isabel Font-Noguera, Rosario Menéndez Villanueva, José Andrés Román Iborra, José Luis Poveda Andrés
• What influences the implementation and sustainability of antibiotic stewardship programmes in hospitals? A qualitative study of antibiotic pharmacists’ perspectives across South West England (31 March, 2021) Free

  Teerapong Monmaturapoj, Jenny Scott, Paula Smith, Margaret C Watson
• Does the use of new cephalosporins follow the authorised, financed and approved indications? A study of their use in routine clinical practice in a tertiary hospital (21 December, 2021)

  Andrés Pintado-Álvarez, Lucia Yunquera-Romero, Ignacio Márquez-Gómez, Rocío Asensi-Díez
• Comparison of area under the curve for vancomycin from one- and two-compartment models using sparse data (20 July, 2021)

  Nyein Hsu Maung, Janthima Methaneethorn, Thitima Wattanavijitkul, Tatta Sriboonruang
• Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin (20 July, 2021)

  Kourosh Sadeghi, Bita Shahrami, Faezeh Hosseini Fani, Hadi Hamishehkar, Mojtaba Mojtahedzadeh
• Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction (29 September, 2021)

  Saeideh Ghaffari, Ali Mohammad Hadi, Farhad Najmeddin, Bita Shahrami, Mohammad-Reza Rouini, Atabak Najafi, Mojtaba Mojtahedzadeh
• Relationship between amikacin pharmacokinetics and biological parameters associated with organ dysfunction: a case series study of critically ill patients with intra-abdominal sepsis (11 November, 2021)

  Bita Shahrami, Aida Sefidani Forough, Seyedeh Sana Khezrnia, Farhad Najmeddin, Amir Ahmad Arabzadeh, Mohammad Reza Rouini, Atabak Najafi, Mojtaba Mojtahedzadeh
• Therapeutic drug monitoring of amikacin: quantification in plasma by liquid chromatography-tandem mass spectrometry and work experience of clinical pharmacists (17 November, 2021)

  Lijie Xu, Xuefang Cheng, Guanhua Zhu, Juanni Hu, Qin Li, Guorong Fan